ArticleEuropean journal of nuclear medicine and molecular imaging2026

Utility of PSMA PET/CT for staging of favourable risk intermediate risk prostate cancer.

Ming Hei Fu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.